15:59 Dec 05

Krebs Biochemicals & Industries Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
68.97
+3.69 (+5.65%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Krebs Biochemicals & Industries Ltd. Financials

Krebs Biochemicals & Industries Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
68.97
+3.69 (+5.65%)
15:59 Dec 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

4/100
Expensive Valuation

Technical

34/100
Technically Bearish

Strength

4

Weakness

10

Opportunity

0

Threats

0

-1,086.69 %

ROE %

-15.93 %

ROA %

-12.74

EPS

-67.83

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
59.7 52.13 50.42 43.31 35.91
Operating Expenses +
93.7 67.92 59.14 58.34 50.82
Raw Material
46.18 19.8 5.52 2.53 2.16
Increase Decrease in Cost
-5.54 5.87 1.07 3.03 2.43
Other Manufacturing Expense
33.06 0 0 0 0
Employee Cost
15.3 15.84 16.47 16.6 15.09
Miscellaneous Expenses
4.7 35.29 36.26 36.26 31.14
Operating Profit
-34 -15.79 -8.72 -15.03 -14.91
Other Income
1.16 0.62 0.45 0.71 0.69
Depreciation
6.3 6.56 6.77 6.69 6.6
Interest
5.39 2.97 4.69 5.91 6.24
Profit before tax and exceptio..
-44.53 -24.69 -19.73 -26.92 -27.06
Exceptional Items
0 0 0 0 0
PBT
-44.53 -24.69 -19.73 -26.92 -27.06
Provision for Taxation
0 0 0 0.02 0.02
Net Profit
-44.53 -24.69 -19.73 -26.94 -27.09
NET Profit after MI
0 0 0 0 0
EPS
-20.81 -11.3 -9.16 -12.49 -12.56
Operating Profit Margin (%)
-56.95 -30.29 -17.29 -34.7 -41.52
Net Profit Margin (%)
-74.59 -47.36 -39.13 -62.2 -75.44

Krebs Biochemicals & Industries Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 72.70 72.70 72.70 72.70 72.70 72.70
FII 0.50 0.50 0.50 0.50 0.50 0.50
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 26.80 26.80 26.80 26.80 26.80 26.80
Shareholder Shares Holding %
Download Our App On: